NeurologyOnline.net

Neurology Xagena

There is increasing evidence that links perturbed sphingolipid metabolism to a range of different neurodegenerative conditions including Huntington’s disease ( HD ). Researchers have consolidated t ...


A new analysis from a pivotal study highlighting the efficacy of Erenumab in patients with 15 or more headache days a month ( chronic migraine ) and a recent history of acute migraine medication overu ...


New analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology ( AAN) in Boston, Massachusetts, were ...


Although Levodopa remains the most effective oral pharmacotherapy for Parkinson disease ( PD ), its use is often limited by wearing off effect and dyskinesias. Management of such complications continu ...


The results of a national survey aimed at quantifying the current level of diffusion of Levodopa and Carbidopa intestinal gel ( LCIG ) in Italy, were reported. Sixty Parkinson's disease specialists ...


Phase III RADIANCE trial, evaluating the efficacy and safety of Ozanimod, an investigational oral, selective S1P 1 and 5 receptor modulator, in patients with relapsing multiple sclerosis ( RMS ), met ...


Multiple sclerosis ( MS ) is increasingly being viewed and studied not only as an immune-mediated demyelinating and neurodegenerative disease of the human central nervous system ( CNS ) but as a vascu ...


Seasonal variation of relapses in multiple sclerosis suggests that season-dependent factors, such as ambient air pollution, may trigger them. However, only few studies have considered possible role of ...


Insufficient sleep, a common problem that has been linked to chronic disease risk, might also be an unrecognized risk factor for bone loss. Results of a new study were presented at the Endocrine Soc ...


The viruses hepatitis B and C may both be associated with an increased risk of Parkinson’s disease, according to a study published in Neurology, the medical journal of the American Academy of Neurolog ...


A study by Indiana University researchers has identified 24 compounds, including Caffeine, with the potential to boost an enzyme in the brain shown to protect against dementia. The protective effec ...


The objective of a study was to determine whether oral anticoagulation treatment ( OAT ) resumption after primary intracerebral hemorrhage ( ICH ) is associated with long-term outcome. Oral anticoa ...


Drugs used to treat diabetes could also be used to treat Alzheimer's disease, according to new research from the University of Aberdeen. This is also the first study of its kind to show that Alzheime ...


According to Iowa State University researchers, higher levels of the enzyme, autotaxin, significantly predict memory impairment and type 2 diabetes. Autotaxin, often studied in cancer research, is ...


Higher Caffeine consumption has been associated with reduced risk of Parkinson's disease, and with a more benign progression of motor and non-motor symptoms. An observational cohort study investigat ...